- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | NT PHARMA (01011): APPOINTMENT OF AUDITOR | - | HKEx | ||
| 04.09. | NT PHARMA (01011): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 04.09. | NT PHARMA (01011): COMPLETION OF CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE | - | HKEx | ||
| 31.08. | NT PHARMA (01011): CHANGE OF (1) COMPANY SECRETARY, (2) AUTHORISED REPRESENTATIVE AND (3) PROCESS AGENT | 1 | HKEx | ||
| 28.08. | NT PHARMA (01011): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 28 AUGUST 2026 | 5 | HKEx | ||
| 20.08. | NT PHARMA (01011): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026 | 2 | HKEx | ||
| 18.08. | NT PHARMA (01011): INSIDE INFORMATION ANNOUNCEMENT ARBITRATION AWARD | 1 | HKEx | ||
| CHINA NT PHARMA Aktie jetzt für 0€ handeln | |||||
| 10.08. | NT PHARMA (01011): DATE OF BOARD MEETING | 1 | HKEx | ||
| 10.08. | NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER | 1 | HKEx | ||
| 10.08. | NT PHARMA (01011): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDER | 5 | HKEx | ||
| 10.08. | NT PHARMA (01011): FORM OF PROXY FOR USE AT EXTRAORDINARY GENERAL MEETING | 3 | HKEx | ||
| 10.08. | NT PHARMA (01011): NOTICE OF EXTRAORDINARY GENERAL MEETING | 1 | HKEx | ||
| 10.08. | NT PHARMA (01011): CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE, APPOINTMENT OF AUDITOR ... | 2 | HKEx | ||
| 31.07. | NT PHARMA (01011): QUARTERLY UPDATES ON THE IMPLEMENTATION OF ACTION PLANS TO RESOLVE THE DISCLAIMER OF OPINION | 2 | HKEx | ||
| 31.07. | NT PHARMA (01011): FURTHER DELAY IN DESPATCH OF CIRCULAR | 3 | HKEx | ||
| 10.07. | NT PHARMA (01011): DELAY IN DESPATCH OF CIRCULAR | - | HKEx | ||
| 07.07. | NT PHARMA (01011): APPOINTMENT OF AUDITOR | - | HKEx | ||
| 03.07. | NT PHARMA (01011): UPDATE ON IMPLEMENTATION OF REMEDIAL ACTIONS AND KEY FINDINGS OF INTERNAL CONTROL REVIEW | 1 | HKEx | ||
| 03.07. | NT PHARMA (01011): CHANGE OF CHIEF EXECUTIVE OFFICER | 2 | HKEx | ||
| 17.06. | NT PHARMA (01011): CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE | 1 | HKEx |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,356 | -0,42 % | Curaleaf Holdings, Inc.: Curaleaf Submits Application to Alberta Securities Commission to Halt Aurora Cannabis' ATM Program During Pending Offer | Argues Aurora's share issuances are an improper and abusive defensive tactic that dilutes shareholders and interferes with consideration of Curaleaf's premium offer
Aurora's... ► Artikel lesen | |
| CANOPY GROWTH | 0,800 | -0,84 % | Canopy Growth Corp (2): Canopy Growth reminds shareholders to vote before AGSM | ||
| TILRAY BRANDS | 3,450 | -0,86 % | BrewDog creditors owed £190m will not be paid in full, say administrators | ||
| DIGICANN VENTURES | 0,005 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| SINOPHARM | 1,655 | +1,04 % | SINOPHARM (01099): ANNOUNCEMENT (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON TUESDAY, 15 SEPTEMBER 2026; AND (2) ELECTION OF CHAIRMAN ... | ||
| CSPC PHARMA | 1,006 | +1,99 % | CSPC PHARMA (01093): NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM | ||
| ORAMED PHARMACEUTICALS | 4,080 | 0,00 % | Oramed Pharmaceuticals: Aktionäre bestätigen Verwaltungsrat und billigen Anpassung des Aktienplans | ||
| ADASTRA | 0,133 | +4,74 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| METRIOPHARM | - | - | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
-- Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of
MetrioPharm... ► Artikel lesen | |
| BAYER | 48,090 | -1,94 % | Platzt der Knoten?: Bayer-Aktie vor dem wichtigsten Glyphosat-Termin der Unternehmensgeschichte? | © Foto: KI-generiert mit DALL-EVor fast 10 Jahren hat Bayer Monsanto übernommen. Damals hat wohl niemand in Leverkusen damit gerechnet, dass eine jahrelange Prozessflut damit verbunden ist. Biegt die... ► Artikel lesen | |
| MERCK KGAA | 129,85 | -1,22 % | Community-Rückblick: "Moderna wäre um min. 50% gestiegen, BioNTech bisher nicht mal 2%. That's it!" | © Foto: Julia Cebella - dpaNeue Onkologie-Daten sorgen bei BioNTech für Diskussionen: Warum reagiert die Aktie trotz guter Studienergebnisse kaum? Die wO User Diskutieren über Pipeline, Bewertung und... ► Artikel lesen | |
| IM CANNABIS CORP | 4,200 | -0,71 % | IM Cannabis Stock Surges 247% | ||
| NOVO NORDISK | 37,580 | -0,12 % | Novo Nordisk öffnet GLP-1 die nächste Tür - warum Big Pharma Milliardenmärkte immer weiter vergrößert | ||
| DERMAPHARM | 38,900 | -0,26 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen |
CHINA NT PHARMA GROUP CO LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA NT PHARMA GROUP CO LTD finden Sie auf Wallstreet Online.